Introduction
Verrucous hemangiomas (VH) are hyperkeratotic vascular malformations characterized by a combination of dilated vasculature in the entire dermis, or even much deeper, and prominent hyperkeratosis, which may result in papules, patches, or violet-colored erythematous tumors. Bleeding after trauma or scratching is frequent. Surgery is nowadays the gold-standard treatment but laser therapy may nevertheless be useful in the superficial component of the lesions. Treatments with argon laser and copper vapor laser have been used [1] , but both are limited by lack of specificity, poor penetration, and adverse sequelae. Recently, the Nd:YAG 1,064-nm laser has been used in a few cases, either alone or combined with CO 2 or the pulsed dye laser (PDL) [2] .
Materials and methods
We report our experience as a tertiary referral hospital laser unit in the treatment of VH with different combinations of laser therapy over the last 10 years: CO 2 laser (10-30 W continuous-wave mode), PDL 595 nm (7 mm, 2 ms, 10-12 J/cm 2 ) and combined dual PDL-Nd:YAG (Cynergy with Multiplex™, Cynosure, Westford, MA) (PDL: 7 mm, 10 ms, 10 J/cm 2 with 1-s delay and Nd:YAG: 15 ms, 50-100 J/ cm 2 ). Continuous airflow cooling (Cryo5s, Zimmer Medizinsysteme GmbH, Neu-Ulm, Germany) was always applied at its maximum level (6) during laser treatment.
Post-laser care consisted of the daily application of topical antibiotic ointment (Fucidine©) until spontaneous detachment of the scab. Strict avoidance of sun exposure of the treated areas was recommended for at least 2 months to avoid postinflammatory hyperpigmentation.
The study period included eight patients (seven female and one male) evaluated for laser treatment of VH. The mean age of the patients was 6.5 years (range: 3-16 years). All the patients presented multiple hyperkeratotic erythematous plaques that had developed in early childhood, located on the lower limbs, except for one on the left forearm (patient number 7). The lesions were heterogeneous with hyperkeratotic areas interspersed with flat incipient vascular lesions with no hyperkeratosis, all representing a challenge in terms of surgical treatment. Biopsies confirmed the diagnosis of VH.
None of the patients had any relevant personal or family history and no muscle or bone involvement was noted with magnetic resonance imaging. All the patients underwent laser treatment under local anesthesia, except for one girl who required general anesthesia. Two dermatologists evaluated the effectiveness of the treatment by means of photographs of the patients before and after the therapy. Ulceration, infection, scarring, atrophy, hypopigmentation, hyperpigmentation, or other side-effects were recorded. Patient satisfaction, or parent satisfaction if the patient was a minor, was rated on a scale from 0 to 10.
Results
The best response in the hyperkeratotic superficial portion was obtained with CO 2 laser, but the superficial and deep vascular components responded better to dual PDL-Nd: YAG laser (Figs. 1-4) . PDL was only useful in very superficial lesions to prevent the development of the early hyperkeratotic component of some of these lesions [3] . Ulceration, scarring, and hypopigmentation can appear but most of the lesions improved markedly, resulting in a better quality of life. No infectious problems were seen in our patients (Table 1) .
Discussion
In 1967, Imperial and Helwig introduced the term "verrucous hemangioma", and defined it as a congenital vascular malformation comprising a capillary or cavernous hemangioma in the dermis and subcutaneous tissue associated with reactive epidermal acanthosis, papillomatosis, and hyperkeratosis, distinguishing it from angiokeratoma [4] . Currently, most authors consider VH to be a malformation of dermal capillaries and encourage use of the term hyperkeratotic vascular malformation to describe this type of vascular change [5] . Nonetheless, the histopathological features and the reactivity against specific immunohistochemical markers (focal GLUT-1 endothelial positivity) have led other authors to be cautious about encompassing VH in the group of vascular malformations or tumors [6] .
Given the clinical course of these lesions, we prefer the term hyperkeratotic vascular malformation.
The lesions are generally noted at birth or in early childhood [7] , although they may appear later or even in adult life. Most VH are multiple lesions and are located on the lower extremities, with unilateral involvement [8] . The The differential diagnosis of VH includes angiokeratoma, lymphangioma circumscriptum, angioma serpiginosum, verrucous epidermal naevus, verrucous cancer, or even malignant melanoma [6-8, 10, 11] . Occasional venous malformations may also mimic VH, though there is usually minimal hyperkeratosis [9] .
Diagnostic histopathological findings are ectatic vessels underlying an acanthotic and hyperkeratotic epidermis in combination with deeply localized vascular formations interspersed with fatty tissue [12] . Inflammatory cells, hemosiderin, and fibrosis may be present in the upper dermis [7] . VH resemble angiokeratoma, although VH involve small, thick-walled, blood-filled vessels with a multilamellated basement membrane involving the dermis as well as fatty tissue [6, 9] .
VH do not resolve spontaneously, and have a tendency to relapse. Early diagnosis and treatment is important to achieve a better cosmetic result [8] . Management of VH has included excision, cautery, cryosurgery, and laser therapy [11, 13] . VH require a large, deep excision because they extend into the subcutis, occasionally involving the fascia. Incomplete extirpation can lead to recurrence [8, 9, 11, 14] . Yang and Ohara performed surgery in combination with PDL, CO 2 laser, or argon laser in 23 patients with VH and reported that a combination approach using surgical reconstruction and laser is necessary for large and extensive lesions [15] . Surgery is even more complicated due to the multiplicity of lesions in the same patient. Although laser treatment is only palliative, it cannot treat the deep component, and requires multiple treatment sessions, as in our patients. It is nevertheless worth using in many patients in an attempt to avoid surgery. Finally, a recent study reported that hypertrophic and PDL-resistant port-wine stains showed improvement with a 755-nm alexandrite laser, which should also be considered in the future as a new therapeutic option for verrucous hemangioma [16, 17] .
Conclusions
Treatment of VH can be difficult and recurrence is common. Surgery should always be considered for these patients, though laser treatment should be tried beforehand, even though it is only palliative. We have observed a very satisfactory response to laser treatment in some circumscribed lesions and partial response of the superficial component of deeper lesions, with an improvement in quality of life and patient satisfaction. Thus, combined laser therapy (CO 2 and dual PDL-Nd:YAG laser) may be useful in most cases of verrucous hemangiomas.
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